Dermira was founded and seed financed in late 2010 by former members of the Peplin and Connetics leadership teams, including Tom Wiggans and Dr. Eugene Bauer together with Bay City Capital based on the belief that while many common yet serious skin conditions have unsatisfactory treatment options, dermatology has attracted limited research resources and investment. They were immediately joined by Chris Griffith, previously at Gilead and Bay City Capital, and Luis Peña, previously at Stiefel, a GSK Company, to launch Dermira, a development stage private biotech company focused on developing and commercializing innovative new therapies in dermatology.

Financials

People